A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores

被引：0

作者：

Takeo Fujii

Hiroko Masuda

Yee Chung Cheng

Fei Yang

Aysegul A. Sahin

Yasuto Naoi

Yuki Matsunaga

Akshara Raghavendra

Arup Kumar Sinha

Jose Rodrigo Espinosa Fernandez

Anjali James

Keisuke Yamagishi

Tomoko Matsushima

Robert Schuetz

Debu Tripathy

Sachiyo Tada

Rubie S. Jackson

Shinzaburo Noguchi

Seigo Nakamura

Jared D. Acoba

Naoto T. Ueno

机构：

[1] The University of Texas MD Anderson Cancer Center,Department of Breast Medical Oncology

[2] The University of Texas MD Anderson Cancer Center,Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, Unit 1354

[3] University of Hawai’i,John A. Burns School of Medicine

[4] University of Hawai’i Cancer Center,Department of Breast Surgical Oncology

[5] Showa University,Division of Hematology and Oncology

[6] Medical College of Wisconsin,Department of Translational Molecular Pathology

[7] The University of Texas MD Anderson Cancer Center,Department of Pathology

[8] The University of Texas MD Anderson Cancer Center,Department of Breast and Endocrine Surgery

[9] Osaka University Graduate School of Medicine,Anne Arundel Medical Center

[10] Sysmex Corporation,undefined

[11] Rebecca Fortney Breast Center,undefined

[12] Hyogo Prefectural Nishinomiya Hospital,undefined

来源：

Breast Cancer Research and Treatment | 2021年 / 189卷

关键词：

Breast cancer; 21-gene signature assay; 95-gene signature assay; Estrogen receptor-positive; Recurrence Score;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：455 / 461

页数：6

共 50 条

[1] A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores
Fujii, Takeo
Masuda, Hiroko
Cheng, Yee Chung
Yang, Fei
Sahin, Aysegul A.
Naoi, Yasuto
Matsunaga, Yuki
Raghavendra, Akshara
Sinha, Arup Kumar
Fernandez, Jose Rodrigo Espinosa
James, Anjali
Yamagishi, Keisuke
Matsushima, Tomoko
Schuetz, Robert
Tripathy, Debu
Tada, Sachiyo
Jackson, Rubie S.
Noguchi, Shinzaburo
Nakamura, Seigo
Acoba, Jared D.
Ueno, Naoto T.
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2021, 189 (02) : 455 - 461
[2] A novel 95-gene signature (Curebest 95GC Breast) that predicts recurrence-risk in patients with ER-positive, HER2-negative, node-negative, early-stage primary invasive breast cancer with an intermediate Oncotype DX Recurrence Score.
Fujii, Takeo
Masuda, Hiroko
Cheng, Yee Chung
Yang, Fei
Sahin, Aysegul A.
Naoi, Yasuto
Matsunaga, Yuki
Raghavendra, Akshara Singareeka
Sinha, Arup Kumar
Fernandez, Jose R. Espinosa
James, Anjali
Yamagishi, Keisuke
Matsushima, Tomoko
Tripathy, Debu
Tada, Sachiyo
Jackson, Rubie S.
Noguchi, Shinzaburo
Nakamura, Seigo
Acoba, Jared David
Ueno, Naoto T.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[3] Comparison of efficacy of 95-gene and 21-gene classifier (Oncotype DX) for prediction of recurrence in ER-positive and node-negative breast cancer patients
Yasuto Naoi
Kazuki Kishi
Ryo Tsunashima
Kenzo Shimazu
Atsushi Shimomura
Naomi Maruyama
Masafumi Shimoda
Naofumi Kagara
Yosuke Baba
Seung Jin Kim
Shinzaburo Noguchi
[J]. Breast Cancer Research and Treatment, 2013, 140 : 299 - 306
[4] Comparison of efficacy of 95-gene and 21-gene classifier (Oncotype DX) for prediction of recurrence in ER-positive and node-negative breast cancer patients
Naoi, Yasuto
Kishi, Kazuki
Tsunashima, Ryo
Shimazu, Kenzo
Shimomura, Atsushi
Maruyama, Naomi
Shimoda, Masafumi
Kagara, Naofumi
Baba, Yosuke
Kim, Seung Jin
Noguchi, Shinzaburo
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 140 (02) : 299 - 306
[5] Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer
Poorvu, Philip D.
Gelber, Shari, I
Rosenberg, Shoshana M.
Ruddy, Kathryn J.
Tamimi, Rulla M.
Collins, Laura C.
Peppercorn, Jeffrey
Schapira, Lidia
Borges, Virginia F.
Come, Steven E.
Warner, Ellen
Jakubowski, Debbie M.
Russell, Christy
Winer, Eric P.
Partridge, Ann H.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (07) : 725 - +
[6] Comparisons of tumor-infiltrating lymphocytes and 21-gene recurrence score in ER-positive/ HER2-negative breast cancer
Ahn, S. G.
Cha, Y. J.
Yoon, C.
Bae, S. J.
Kim, J.
Jeong, J.
[J]. ANNALS OF ONCOLOGY, 2017, 28
[7] Development of recurrence risk score using 95-gene classifier and its application to formalin-fixed paraffin-embedded tissues in ER-positive, HER2-negative and node-negative breast cancer
Naoi, Yasuto
Saito, Yuria
Kishi, Kazuki
Shimoda, Masafumi
Kagara, Naofumi
Miyake, Tomohiro
Tanei, Tomonori
Shimazu, Kenzo
Kim, Seung Jin
Noguchi, Shinzaburo
[J]. ONCOLOGY REPORTS, 2019, 42 (06) : 2680 - 2685
[8] Evaluation of 95-Gene Classifier of Formalin-fixed Paraffin-embedded Tissues in ER-positive, HER2-negative, and Node-negative Breast Cancer
Yamashita, Hiroko
Hatanaka, Kanako C.
Yamagishi, Keisuke
Saito, Yuria
Hamasaki, Kengo
Taniguchi, Mitsuru
Okumura, Asami
Nange, Ayae
Matsuno, Yoshihiro
Hatanaka, Yutaka
[J]. ANTICANCER RESEARCH, 2023, 43 (02) : 707 - 711
[9] Prognostic value of the 21-gene recurrence score in ER-positive,HER2-negative, node-positive breast cancer was similar in node-negative diseases: a single-center study of 800 patients
Jiayi Wu
Weiqi Gao
Xiaosong Chen
Chunxiao Fei
Lin Lin
Weiguo Chen
Ou Huang
Siji Zhu
Jianrong He
Yafen Li
Li Zhu
Kunwei Shen
[J]. Frontiers of Medicine., 2021, 15 (04) - 628
[10] Prognostic value of the 21-gene recurrence score in ER-positive, HER2-negative, node-positive breast cancer was similar in node-negative diseases: a single-center study of 800 patients
Jiayi Wu
Weiqi Gao
Xiaosong Chen
Chunxiao Fei
Lin Lin
Weiguo Chen
Ou Huang
Siji Zhu
Jianrong He
Yafen Li
Li Zhu
Kunwei Shen
[J]. Frontiers of Medicine, 2021, 15 : 621 - 628

← 1 2 3 4 5 →